EyePoint (EYPT) Cash from Operations Growth (5y) (2015 - 2026)
EyePoint (EYPT) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | EyePoint | 1.06 Mn | -221.49 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.77% |
| Dec 31, 2025 | -67.12% |
| Sep 30, 2025 | -122.27% |
| Jun 30, 2025 | -64.98% |
| Mar 31, 2025 | -26.58% |
| Dec 31, 2024 | -25.56% |
| Sep 30, 2024 | -21.45% |
| Jun 30, 2024 | -3.36% |
| Mar 31, 2024 | -18.51% |
| Dec 31, 2023 | -0.46% |
| Sep 30, 2023 | 7.68% |
| Jun 30, 2023 | 48.54% |
| Mar 31, 2023 | -28.43% |
| Dec 31, 2022 | -25.23% |
| Sep 30, 2022 | -17.09% |
| Jun 30, 2022 | -33.84% |
| Mar 31, 2022 | -34.72% |
| Dec 31, 2021 | -27.18% |
| Sep 30, 2021 | -3.72% |
| Jun 30, 2021 | -19.39% |